JAKARTA – In a significant move signaling robust conviction, Pyridam Farma (PYFA)’s controlling shareholder, Rejuve Global Investment Pte. Ltd., has substantially increased its ownership. This strategic acquisition, valued at hundreds of billions of rupiah, underscores the investor’s unwavering belief in the pharmaceutical company’s future trajectory.
Controlling Shareholder Fortifies Position with Major Share Buy
On February 12, 2026, Rejuve Global Investment Pte. Ltd. executed a massive share purchase, acquiring approximately 430 million shares of PYFA. This transaction was conducted at an average price of Rp405 per share, culminating in a total investment of roughly Rp174.2 billion. The details of this significant trade are publicly available, confirming the transparency of the move. This substantial acquisition effectively boosts Rejuve Global Investment’s direct ownership in PYFA from approximately 60.46% to a more dominant 64.02%.
Why Insider Buying Matters: A Strong Vote of Confidence
When a controlling shareholder like Rejuve Global Investment significantly increases its stake, it’s often interpreted by the market as a powerful vote of confidence. This move suggests that the insider, possessing intimate knowledge of the company’s operations, strategic plans, and growth prospects, believes the stock is currently undervalued or poised for substantial future appreciation. For PYFA investors, this action could serve as a bullish indicator, reflecting an internal assessment of strong fundamentals and promising long-term value in Indonesia’s dynamic pharmaceutical sector.
Market Implications: PYFA’s Future Outlook
The increased ownership by Rejuve Global Investment could herald a period of intensified strategic direction and stability for Pyridam Farma. With a stronger hold, the controlling entity may have greater flexibility to implement long-term growth initiatives, expand market reach, or pursue innovative product development. In an industry as vital as pharmaceuticals, such focused leadership is paramount. Investors will be keenly watching how this reinforced ownership translates into tangible operational improvements and ultimately, enhanced shareholder value for PYFA.